Outsourced Pharma App Notes & Case Studies

  1. Diversifying Single-Use Technology With Cytiva XDR Bioreactors 3/25/2025

    Explore how our flexible single-use bioreactor systems, including the Cytiva Xcellerex Disposable Reactors, can efficiently scale your production while maintaining process consistency and product quality.

  2. Overcome Common Pre-Filled Syringe Challenges Through Partnership 5/23/2025

    The pre-filled syringe space is one of the fastest growing pharma sectors, offering greater patient safety and lower manufacturing costs. But pre-filled doesn’t translate to easily filled; there are particular obstacles to overcome.

  3. CDMO Uses Robotic Gloveless Isolator For Advanced Therapeutics 4/28/2025

    CDMOs must innovate production architectures to meet the demands of advanced therapeutics to ensure a reliable supply and compliance. Discover how these approaches advance modern medicine and improve patient outcomes.

  4. Achieving Faster Timelines And Cost Savings Through Digital Validation 2/11/2025

    Examine how the Project Ready program was leveraged to streamline validation processes for a CDMO, resulting in a 25% reduction in budget and faster project completion.

  5. Review Of Applications And Processes In Fixed-Bed Bioreactors 5/6/2024

    Gain insights and guidelines for developing new processes in this review evaluating publications on the applications of single-use, scalable fixed-bed bioreactors for adherent cell culture processes.

  6. Elevating Downstream Process Development With Real-Time Data Monitoring 7/11/2025

    Learn how real-time monitoring with PAT enhances process control, shortens development timelines, and supports the shift toward continuous manufacturing in biopharmaceutical production.

  7. Optimizing Bispecific Antibody Expression Via Multi-Omics Analysis And Vector Redesign 12/17/2025

    Discover how diagnosing ribosome pausing sites and optimizing codon usage dramatically improves bispecific antibody titers, turning difficult-to-express candidates into viable therapeutics.

  8. Improve Speed To Market By Mitigating Vial And Stopper Incompatibility 10/1/2024

    These studies indicate that with a properly assembled vial containment system, good CCI performance can be achieved with stoppers of a given elastomer, independent of configuration/size, or vial style.

  9. Improving Efficiency In Contamination Identification 7/11/2025

    Discover how rapid microbial identification using MALDI-TOF improves contamination response, shortens investigation timelines, and enhances efficiency in biopharmaceutical manufacturing.

  10. Digitized Solutions To Increase Visibility And Streamline Communication Between A PSP And Manufacturer 2/18/2026

    When email-based escalation management creates compliance and visibility gaps, a centralized digital solution helps manufacturer and PSP teams act faster and with greater accountability.